Ogen and Injection site pain - a phase IV clinical study of FDA data

Summary:

Injection site pain is reported as a side effect among people who take Ogen (estropipate), especially for people who are female, 50-59 old, also take Humira, and have Pain.

The phase IV clinical study analyzes which people have Injection site pain when taking Ogen. It is created by eHealthMe based on reports of 2,536 people who have side effects when taking Ogen from the FDA, and is updated regularly.

What is Ogen?

Ogen has active ingredients of estropipate. eHealthMe is studying from 2,553 Ogen users. Check the latest studies of Ogen.

What is Injection site pain?

Injection site pain is found to be associated with 1,873 drugs and 1,943 conditions by eHealthMe. Check the latest studies of Injection site pain.

On Jul, 20, 2026

2,536 people reported to have side effects when taking Ogen.
Among them, 12 people (0.47%) have Injection site pain.

Among these 12 people:

What is the gender of people who have Injection site pain when taking Ogen? *

female: 100 %
male: 0.0 %

What is the age of people who have Injection site pain when taking Ogen? *

What are other drugs people take besides Ogen? *

What are other side effects people have besides Injection site pain? *

Nausea And Vomiting: 3 people, 25.00%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 2 people, 16.67%
Pain: 2 people, 16.67%
Injection Site Haemorrhage (bleeding from injection site): 2 people, 16.67%
Oedema Peripheral (superficial swelling): 2 people, 16.67%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 16.67%
Pneumonia: 2 people, 16.67%
Headache (pain in head): 2 people, 16.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 16.67%
Eye Pain: 2 people, 16.67%

What are the existing conditions these people have? *

Pain: 3 people, 25.00%
Stress And Anxiety: 2 people, 16.67%
Sleep Disorder: 2 people, 16.67%
Diabetes: 2 people, 16.67%
High Blood Cholesterol: 2 people, 16.67%
Migraine (headache): 2 people, 16.67%
Uveitis (inflammation of the uvea): 1 person, 8.33%
Hot Flush (sudden feelings of heat): 1 person, 8.33%
Blood Pressure Abnormal: 1 person, 8.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ogen and have Injection site pain?

- Check whether Injection site pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ogen:

Ogen (2,553 reports)

Browse all side effects of Ogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site pain:

Injection site pain (1,873 drugs)

Browse all the conditions that are associated with Injection site pain:

Injection site pain (1,943 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on estropipate (the active ingredients of Ogen) and Ogen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.